Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review

BACKGROUND: Asthma is a highly prevalent chronic inflammatory airways disease, with a considerable impact on quality of life (QoL). To express the effects of asthma on patients’ subjective experience, patient-reported outcomes (PROs) represent an important instrument. The asthma QoL questionnaire (A...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Adv Respir Dis
Egile Nagusiak: Colombo, Giorgio Lorenzo, Di Matteo, Sergio, Martinotti, Chiara, Oselin, Martina, Valentino, Maria Chiara, Bruno, Giacomo Matteo, Pitotti, Claudia, Menzella, Francesco
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2019
Gaiak:
Systematic Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492364/
https://ncbi.nlm.nih.gov/pubmed/31035904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466619841350
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak